Riverain Medical, a leading image enhancement and computer-aided detection company dedicated to providing physicians with tools to assist in image interpretation, announced that the U.S. Food and Drug Administration (FDA) has cleared the SoftView Enhanced Chest Imaging technology.
SoftView suppresses ribs and clavicles on chest X-rays to produce a soft tissue image that increases clarity and improves the detection of lung nodules. This technology uses existing X-ray equipment to provide a soft tissue image for digital chest X-rays. SoftView delivers no additional radiation dose to the patient and does not require any additional patient procedures or specialized equipment.
SoftView uses image processing and pattern recognition technologies to suppress bone in the chest X-ray. The resulting soft tissue image improves the visibility of tissue within the lung.
source: Riverain Medical
No comments:
Post a Comment